您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > (±)14(15)-EET-d11
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
(±)14(15)-EET-d11
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
(±)14(15)-EET-d11图片
规格:98%
分子量:331.5
包装与价格:
包装价格(元)
25ug电议
50ug电议
100ug电议

产品介绍
A neuropeptide with diverse biological activities
货号:ajcx20832
CAS:N/A
分子式:C20H21D11O3
分子量:331.5
溶解度:DMF: 50 mg/ml,DMSO: 50 mg/ml,Ethanol: 50 mg/ml,PBS (pH 7.2): 1 mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

(±)14(15)-EET-d11is intended for use as an internal standard for the quantification of (±)14(15)-EET by GC- or LC-MS. (±)14(15)-EET is a metabolite of arachidonic acid that is formedviaepoxidation of arachidonic acid by cytochrome P450.1,2It prevents increases in leukotriene B4, ICAM-1, and chemokine (C-C motif) ligand 1 (CCL2) induced by oxidized LDL in primary rat pulmonary artery endothelial cells (RPAECs) when used at a concentration of 1 μM.3(±)14(15)-EET induces dilation of preconstricted isolated canine coronary arterioles (EC50= 0.2 pM).4It reduces myocardial infarct size as a percentage of the area at risk in a canine model of ischemia-reperfusion injury induced by left anterior descending coronary artery (LAD) occlusion when administered at a dose of 0.128 mg/kg prior to occlusion or reperfusion.5


1.Chacos, N., Falck, J.R., Wixtrom, C., et al.Novel epoxides formed during the liver cytochrome P-450 oxidation of arachidonic acidBiochem. Biophys. Res. Commun.104(3)916-922(1982) 2.Oliw, E.H., Guengerich, F.P., and Oates, J.A.Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediatesJ. Biol. Chem.257(7)3771-3781(1982) 3.Jiang, J.-X., Zhang, S.-J., Xiong, Y.-K., et al.EETs attenuate ox-LDL-induced LTB4 production and activity by inhibiting p38 MAPK phosphorylation and 5-LO/BLT1 receptor expression in rat pulmonary arterial endothelial cellsPLoS One10(6)e0128278(2015) 4.Oltman, C.L., Weintraub, N.L., VanRollins, M., et al.Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculationCirc. Res.83(9)932-939(1998) 5.Nithipatikom, K., Moore, J.M., Isbell, M.A., et al.Epoxyeicosatrienoic acids in cardioprotection: Ischemic versus reperfusion injuryAm. J. Physiol. Heart Circ. Physiol.291(2)H537-H542(2006)